Whittier Trust Co. Has $10.47 Million Stock Position in GE HealthCare Technologies Inc. $GEHC

Whittier Trust Co. boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 148,659 shares of the company’s stock after buying an additional 13,642 shares during the quarter. Whittier Trust Co.’s holdings in GE HealthCare Technologies were worth $10,466,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Auto Owners Insurance Co boosted its holdings in GE HealthCare Technologies by 9,525.4% in the fourth quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock valued at $278,725,000 after acquiring an additional 33,629,559 shares during the last quarter. Norges Bank bought a new position in GE HealthCare Technologies during the 4th quarter worth approximately $596,024,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $533,655,000. Capital Research Global Investors lifted its position in shares of GE HealthCare Technologies by 25.0% in the 3rd quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock worth $1,875,400,000 after purchasing an additional 4,998,154 shares during the period. Finally, Cynosure Group LLC boosted its stake in shares of GE HealthCare Technologies by 21,045.4% in the 4th quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock valued at $358,055,000 after purchasing an additional 4,344,817 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CFO James Saccaro bought 3,310 shares of the stock in a transaction dated Friday, May 1st. The shares were bought at an average cost of $60.60 per share, for a total transaction of $200,586.00. Following the purchase, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Frank R. Jimenez purchased 1,750 shares of the business’s stock in a transaction that occurred on Thursday, April 30th. The stock was bought at an average cost of $60.45 per share, for a total transaction of $105,787.50. Following the completion of the acquisition, the insider directly owned 93,932 shares in the company, valued at $5,678,189.40. The trade was a 1.90% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders have bought 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several research firms have recently weighed in on GEHC. Royal Bank Of Canada assumed coverage on shares of GE HealthCare Technologies in a research report on Tuesday, June 23rd. They set an “outperform” rating and a $80.00 price objective for the company. Argus cut their price target on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a research report on Tuesday, May 19th. The Goldman Sachs Group reiterated a “neutral” rating on shares of GE HealthCare Technologies in a report on Monday, June 8th. Evercore set a $80.00 price objective on GE HealthCare Technologies in a research report on Thursday, April 30th. Finally, JPMorgan Chase & Co. dropped their price objective on GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th. Ten analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $80.20.

GE HealthCare Technologies Stock Up 0.6%

GEHC stock traded up $0.37 during trading on Tuesday, reaching $65.21. The stock had a trading volume of 588,915 shares, compared to its average volume of 4,350,446. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95. The company has a market capitalization of $29.67 billion, a price-to-earnings ratio of 15.61, a P/E/G ratio of 1.78 and a beta of 0.72. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The company’s 50 day moving average is $63.60 and its two-hundred day moving average is $73.09.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing the consensus estimate of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The firm had revenue of $5.13 billion for the quarter, compared to the consensus estimate of $5.04 billion. During the same period in the prior year, the business earned $1.01 EPS. GE HealthCare Technologies’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be given a $0.035 dividend. The ex-dividend date of this dividend is Friday, July 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 3.35%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.